OBETAS 120 (ORLISTAT 120MG) WEIGHT LOSS in Kenya

OBETAS 120 (Orlistat 120mg) is a gastric and pancreatic lipase inhibitor specifically designed to limit the absorption of dietary fat, making it a key player in the management of weight loss in Kenya. This medication is effective when combined with dietary modifications for patients who are classified as obese, with a body mass index (BMI) of 30 kg/m² or greater. It can also be utilized for overweight individuals with a BMI of 28 kg/m² or higher, particularly if they have associated risk factors such as diabetes or hypertension.

OBETAS 120 for Weight Loss in Kenya

For those seeking effective solutions for weight loss in Kenya, OBETAS 120 serves as a valuable option. Before starting treatment, it is essential that patients achieve a preliminary weight loss of at least 2.5 kg over four consecutive weeks through dietary changes alone. This ensures that OBETAS 120 is introduced as a supportive measure rather than a standalone solution.

How to Use OBETAS 120 for Weight Loss in Kenya

The recommended dosage for OBETAS 120 is 120 mg taken by mouth three times a day, ideally before, during, or within one hour after meals. If a meal is missed or contains no fat, the dose should be skipped. It is crucial for patients to monitor their progress; therapy with OBETAS 120 should be discontinued if there is no weight loss of at least 5% of the initial body weight during the first 12 weeks of treatment.

Precautions When Using OBETAS 120 for Weight Loss in Kenya

Patients in Kenya should be aware that OBETAS 120 should not be administered to those with chronic malabsorption syndrome or cholestasis. Caution is advised for individuals with a history of hyperoxaluria or calcium oxalate nephrolithiasis. Additionally, patients with type II diabetes may need adjustments to their hypoglycaemic medications due to improved metabolic control following weight loss. It is also important to consider that long-term users may require supplements of fat-soluble vitamins, which should be taken at least two hours before or after an OBETAS 120 dose. Do not use when pregnant.

Drug Interactions with OBETAS 120

OBETAS 120 may interfere with the absorption of fat-soluble vitamins, including Omega 3 and Cod Liver Oil. It is advised not to combine this medication with acarbose. Patients on anticoagulants like warfarin should have their international normalized ratio (INR) monitored while using OBETAS 120, as interactions can affect therapeutic levels. There have also been reports of reduced ciclosporin concentrations in transplant recipients using this medication.

Side Effects of Xenical  for Weight Loss in Kenya

The most common adverse effects associated with OBETAS 120 include gastrointestinal disturbances such as faecal urgency, flatulence, and oily stools. These symptoms can often be alleviated by adhering to a low-fat diet. Other reported side effects may include headache, anxiety, fatigue, and menstrual irregularities. While concerns about a potential increased risk of breast cancer with Orlistat use have been raised, manufacturers assert that there is no definitive evidence linking the two.

Achieving Weight Loss in Kenya with OBETAS 120

OBETAS 120 (Orlistat 120mg) presents a practical option for individuals aiming for weight loss in Kenya. By inhibiting fat absorption and supporting dietary efforts, it can facilitate significant weight loss when used responsibly. However, it is essential for patients to follow medical advice and maintain healthy lifestyle choices for the best results.